Your web browser is out of date. Update your browser for more security, speed and the best experience on this site

CS
Group leader

Pavel Majer

Pavel Majer
Contacts
pavel.majerinvalid-email-name@invalid-email-domainuochb.cas.cz
+420 220183125
Group
Drug Discovery
Pavel Majer Group
All publications

Recent papers

Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure–Activity Relationship and Binding Mode Analysis
R. Houštecká M. Hadzima J. Fanfrlík J. Brynda L. Pallová I. Hánová H. Mertlíková-Kaiserová M. Lepšík M. Horn
M. Smrčina
P. Majer M. Mareš
Journal of Medicinal Chemistry 63 (4): 1576-1596 (2020).
Go to the publication arrow
The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor
K. M. Lemberg
L. Zhao
Y. Wu
V. Veeravalli
J. Alt
J. M. H. Aguilar
R. P. Dash
J. Lam
L. Tenora
C. Rodriguez
M. T. Nedelcovych
C. Brayton
P. Majer
J. O. Blakeley
R. Rais
B. S. Slusher
Molecular Cancer Therapeutics 19 (2): 397-408 (2020).
Go to the publication arrow
Enhanced Oral Bioavailability of 2-(Phosphonomethyl)-pentanedioic Acid (2-PMPA) from its (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (ODOL)-Based Prodrugs
R. P. Dash
T. Tichý
V. Veeravalli
J. Lam
J. Alt
Y. Wu
L. Tenora P. Majer
B. S. Slusher
R. Rais
Molecular Pharmaceutics 16 (10): 4292-4301 (2019).
Go to the publication arrow
Investigation of flexibility of neuraminidase 150-loop using tamiflu derivatives in influenza A viruses H1N1 and H5N1
V. Zima C. B. Albinana K. Rojíková J. Pokorná P. Pachl P. Řezáčová
J. Hudlicky
V. Navrátil P. Majer J. Konvalinka M. Kožíšek A. Machara
Bioorganic and Medicinal Chemistry 27 (13): 2935-2947 (2019).
Go to the publication arrow